Xueba's life simulator

Chapter 222 New plan

After the mathematicians who studied the Riemann conjecture agreed that the Riemann conjecture had been solved by Zhou Ming and announced the result to the public, various official media at home and abroad also began to report the news.

When Zhou Ming announced his process of proving Riemann's conjecture, although it was also on domestic hot searches, no official media reported that Zhou Ming had solved Riemann's conjecture.

After all, at that time, Zhou Ming was the only one who said that he had solved the Riemann conjecture, but he was not unanimously recognized by his colleagues in the field of mathematics.

Now, since everyone in the field of mathematics, both domestic and foreign, agrees that the Riemann conjecture has indeed been solved by Zhou Ming, then the domestic official media will naturally start to report on this matter in an all-round way.

Whether it is newspapers, television, radio or the Internet, all have reported on this news, and ordinary people in China have gradually learned about it.

Although many people do not know what the Riemann conjecture is, this does not prevent them from watching the news with gusto, because it is not the honor of one person, but the honor of a group of people.

After the Lantern Festival, Zhou Ming's parents and his grandparents all moved to Luzhou.

And after Zhou Ming proved that Riemann's conjecture was reported overwhelmingly by major official media, Zhou Ming's family also soon found out about it, and Zhou Ming's grandma even called Zhou Ming.

The reason why they called instead of talking to Zhou Ming face to face was because Zhou Ming was busy conducting experiments on Alzheimer's disease and making a development plan for a virtuous circle in the countryside. He even slept directly in the In the office, there is really not much free time.

Zhou Ming's family also knew that Zhou Ming was busy, so they did not go to school to disturb him.

If they came to the school, then Zhou Ming would definitely have to show them around, at least it would take half a day, but if they didn't come to find Zhou Ming, then why did they come?
Because of Zhou Ming's assiduous experimentation, the initial stage of Alzheimer's disease was completed very quickly.

At the end of March, Zhou Ming wrote a paper on the experimental process and experimental results. After submitting the paper to "Nature" and announcing the results of his laboratory to the outside world, Future Biotechnology Company also officially announced their results to the outside world. Things to look into for Alzheimer's drugs.

As soon as the news of Future Biotechnology Company was released, it immediately set off a huge wave in the biological circle, especially in the field of brain diseases.

Some people even jokingly said on the Internet that all the hot searches on the Internet are now surrounded by Zhou Ming.

From January at the beginning of this year, Zhou Ming participated in the Cole Number Theory Award and the Huaguo National Science and Technology Award in the Great Hall of the capital through the Internet and won the first prize of the National Natural Science Award. In February, he was first recognized by the mathematics community. Regarding the proof of Riemann's conjecture, in March, the experimental results on Alzheimer's disease were first announced, and then it was announced that it would study drugs on Alzheimer's disease.

In just two months, Zhou Ming has been on the hot searches.

It can even be said that it is not an exaggeration to say that Zhou Mingjing has improved the domestic network environment a little by himself.

Then, why did the future smart technology company announce to the outside world that after they started to study the drug for Alzheimer's disease, such a news would cause huge waves in the field of brain diseases, and even in the entire biological field?
The news released by Future Biotechnology Company to the outside world is not exaggerated, and it did not say that the drug they want to develop can cure patients with Alzheimer's disease.

In the news they released, what they said is that even if the drug they developed is successful, it can only greatly slow down the aggravation of the early stage of Alzheimer's disease, and there is a part of the probability of showing Alzheimer's disease. When the initial precursor of Haimer's disease, the disease will not increase.

However, just such a piece of news can still be said to be a very shocking event in the field of encephalopathy and biomedicine.

Because in terms of the current medical technology and related theoretical basis, it is impossible for Alzheimer's patients to recover.

Although many scholars around the world are conducting research in this area, their biggest goal is to slow down the progress of the patient's condition. If they can maintain the current level and stop developing, this is already the end of all research. The most ideal target for scholars with Alzheimer's disease.

After all, Alzheimer's disease is a disease caused by the degeneration of the body's central nervous system. Otherwise, this disease, commonly known as senile dementia, would not be called God's most vicious curse.

Now, Future Biotech says they can develop a drug that can almost control Alzheimer's patients in the early and middle stages of the disease, which is only one step away from the ideal goal of biologists who study the field. One step away.

More importantly, people who can pay attention to this news must not suffer from Alzheimer's disease, or even if they have Alzheimer's disease, they are still in the early stages.

Not to mention the severe dementia stage of the third stage in the later stage, but the moderate dementia stage of the second stage, which is manifested by severe impairment of near and far memory, decline in visual-spatial ability of simple structures, time and place orientation disorders, and problems in processing. , Severe impairment in discerning similarities and differences between things.

In addition, patients with severe dementia cannot carry out outdoor activities independently, and need help in dressing, personal hygiene, and maintaining personal appearance. He admitted that his emotions also changed from apathy to restlessness, he often walked around, and he also had urinary incontinence.

Such a person has little ability to understand the meaning of this clause issued by the future biotechnology company.

And although the current research says that Alzheimer's disease is related to factors such as family history, female gender, head trauma, low education level, thyroid disease, high or low maternal age, and viral infection, Zhou Ming knows that this disease is Not picky.

Even if some people were very prestigious professors in the past and were very knowledgeable, they will still suffer from Alzheimer's disease when they get old.

Even though some people have not finished elementary school, they still have a clear mind and have no signs of Alzheimer's disease even if they live to be more than 90 or even more than 100 years old.

Scholars who study Alzheimer's disease may also suffer from this disease in the future.

If what the future biotech companies say is true, then there is a good chance that they will not suffer as much in the future as so many late-stage Alzheimer's patients they have seen or known about before.

Alzheimer's disease has reached the third stage of severe dementia in the late stage. Patients have to completely rely on their caregivers for their daily life, eating, drinking, and laxity. At this time, their memory is severely lost, and only fragments of memories Memory, daily life can not take care of themselves, the size is even incontinence...

The more people who understand Alzheimer's disease, the less they want them to become like this when they get old. This appearance is not only a great torture and humiliation for the patient, but also for taking care of his children or other people. It is also very torturous for caregivers.

The reason why it is said that it is a kind of humiliation to the patient, just imagine, a scholar who was once gentle, polite and well-known, has become a baby who may solve the problem of defecation and defecation on the body at any time. The problem is that I often say something that doesn't match the preamble, and the teacher loses his temper for no reason at all times...

This behavior is completely different from before. If the patient is still aware, wouldn't he think it is a humiliation?If euthanasia was available, most of them would probably choose euthanasia.

……

"Some research on how epigenetics affects the nervous system, causing Alzheimer's disease"

In the editorial department of "Nature", an article with such a title is being read by many editors.

Due to the experimental results announced by Zhou Ming and the research plan announced by Future Biotechnology Company, the article submitted by Zhou Ming to "Nature" was collectively reviewed by the editors of the journal the next day, in order to publish it in the latest issue earlier. issue of Nature.

"His article is the same as the title, mainly through some research to prove that the main cause of Alzheimer's disease is actually epigenetics.

He used epigenetics to analyze the engineering of the proliferation and differentiation of hippocampal neural stem cells to produce new neurons in the brains of ordinary adult subjects and Alzheimer's patients. Both correct development and establishment of functional linkages are critical.

In addition, his article also mentioned the key role of epigenetic influence on the brain's neuroimmunity, neurotransmitters and other aspects in Alzheimer's disease. "

"I remember that this Chinese man also studied the relationship between epigenetics and aging before, and his article is also related to epigenetics and aging. With so many experimental data, I don't know if he studied epigenetics before. Accumulated during the relationship with aging."

"I heard that some time ago it was the Spring Festival in Huaguo, which is a very important festival in Huaguo. Zhou Ming must have started researching this aspect before. If he started researching after the Spring Festival, then There is absolutely not enough time."

"Although some of the ideas in this article are very novel and can also promote the research of Alzheimer's disease, I think it is still unrealistic to use this to study drugs that inhibit the early stage of Alzheimer's disease. .”

In the editorial department of the "Nature" journal, after reading Zhou Ming's article one after another, the editors also started to discuss it.

"This future biotechnology company has also issued some plans before, and all of them have been completed. I think they can complete it this time."

"I think it would be great if this company goes public. I will definitely buy their stocks immediately, and I will definitely make a lot of money later."

"Hmph, that's not necessarily true. I heard that most of the money of that future biotechnology company is invested in a company called Future Smart Technology, and their company conducts a lot of research at the same time.

If the capital chain in the middle is broken, it may be like removing the most critical building block in a building made of building blocks, and the entire enterprise will collapse. "

……

Soon after, Zhou Ming's article was published in the latest issue of "Nature".

Later, the research and development of drugs for Alzheimer's disease will be handed over to the company, and Zhou Ming will start new research.

Zhou Ming is going to set up a brand new experimental group this time. The research this new experimental group will conduct is about cloning technology.

Cloning technology is a pure cell line formed by the division and reproduction of the same ancestor cell, and each cell in the cell line is genetically identical to each other.

As early as 1963, ***.S.Haldane used the term "Clone" in his speech entitled "The Biological Possibility of the Human Race in the Next [-] Years".

In 1996, Dolly the sheep, the first successfully cloned mammal, was born.

After decades of development, cloning technology has gone through three periods of development.

The first stage is microbial cloning, that is, using one bacterium to quickly reproduce thousands of bacteria that are exactly the same as it, so that it becomes a bacterial group.

The second period is biotechnology cloning, such as using genetic genes-DNA cloning.

The third period is animal cloning, that is, a cell is cloned into an animal. The first successful mammalian clone, Dolly the sheep, was cloned from the somatic cells of an ewe. Animal cloning technology.

However, although cloning technology has been developed for so many years, it is still impossible to use cloning technology to replace human organs with current technology.

It has also been mentioned before that using cloning technology to cultivate a person whose genes are exactly the same as yours, and then extracting the organs you need from this person.

This is obviously against ethics and morals, and even if you clone it, you need to grow it up like a normal person, which is not realistic to operate.

Because of these reasons, people have proposed another method to replace human organs, which is to use science and technology to cultivate somatic cells in the direction people need.

For example, if the kidneys, arms, eyes, etc. are damaged, cloning technology can be used to cultivate designated organs and transplant them to patients.

Because it is the same gene, there is absolutely no need to worry about rejection in such an organ transplant.

However, these are all just thinking about it until now, and it is far from being possible with the current technology.

The new experimental team that Zhou Ming wants to set up will conduct research on cloning technology in this area.

In the future, although it is still not possible to replace any broken parts of the body regardless of age or physical condition, it will be possible to some extent through advanced technologies such as cloning technology and cell culture technology. The cloning of specific organs has been achieved.

Even in the more distant future, it is already possible to use patients' cells to 3D print parts of organs that need to be replaced.

Of course, for an organ as important as brain tissue, the future that Zhou Ming knew could not be completely cloned and replaced.

In any case, these are also one of the reasons why the average life expectancy of human beings can increase significantly in the future.

(End of this chapter)